Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study

Abstract

Aims/hypothesis The aims of the study were to examine whether type 2 diabetes mellitus is associated with greater brain atrophy and cognitive decline, and whether brain atrophy mediates associations between type 2 diabetes and cognitive decline. Methods Participants without dementia aged 55-90 years from the Cognition and Diabetes in Older Tasmanians (CDOT) study underwent brain MRI (ventricular and total brain volume) and neuropsychological measures (global function and seven cognitive domains) at three time points over 4.6 years. Mixed models were used to examine longitudinal associations of type 2 diabetes with cognitive and MRI measures, adjusting for covariates. A test of mediation was used to determine whether brain atrophy explained associations between type 2 diabetes and cognitive decline. Results A total of 705 participants (diabetes: n = 348, mean age 68.2 years [SD 7.0]; no diabetes: n = 357, mean age 72.5 years [SD 7.1]) were available at baseline. Adjusting for age, sex, education and vascular risk factors, there were significant diabetes × time interactions for verbal memory (β −0.06; 95% CI −0.09, −0.02) and verbal fluency (β −0.03; 95% CI −0.06, −0.00). Although people with diabetes had lower brain (β −14.273; 95% CI −21.197, −6.580) and greater ventricular (β 2.672; 95% CI 0.152, 5.193) volumes at baseline, there were no significant diabetes × time interactions (p > 0.05) or evidence of mediation of the diabetes-cognition relationship by brain atrophy. Conclusions/interpretation In older community-dwelling people, type 2 diabetes is associated with decline in verbal memory and fluency over~5 years. The effect of diabetes on brain atrophy may begin earlier (midlife). KeywordsBrain atrophy . Brain imaging . Cognition . Dementia . Longitudinal study . Type 2 diabetes mellitus Abbreviations DBP Diastolic blood pressure SBP Systolic blood pressure WMH White matter hyperintensityElectronic supplementary material The online version of this article (https://doi.org/10.1007/s00125-018-4778-9) contains peer-reviewed but unedited supplementary material, which is available to authorised users.

The Longitudinal Association Between Cardiovascular Risk and Cognitive Function in Middle-Aged and Older Adults in China: A Nationally Representative Cohort Study

“…Regarding the association between CVR and cognitive function, our results were consistent with previous original articles in older adults (27)(28)(29)(30)(31). The association remains significant even after adjusting other demographic and socioeconomic covariates, indicating CVR might be an independent factor for cognition.…”

Brain Insulin Resistance and Hippocampal Plasticity: Mechanisms and Biomarkers of Cognitive Decline

“…Numerous clinical studies revealed worse cognitive performance and earlier age incidence of all-cause dementia in subjects with T2D (Davis et al, 2017; Callisaya et al, 2019). Accordingly, meta-analysis studies showed that in diabetic patients the risk for all types of dementia is increased by 60–73% (Gudala et al, 2013; Chatterjee et al, 2016).…”

Observational Study of Brain Atrophy and Cognitive Decline Comparing a Sample of Community-Dwelling People Taking Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Over Time

“…Both groups were followed up twice at approximately 2 and 4 years after baseline assessment. For this analysis, additional exclusion criteria included a history of dementia or Parkinson's disease (determined by selfreport using a standardized questionnaire) [19]. Ethics approval was obtained from the Southern…”

“…Domain scores with more than one cognitive test were re-standardized to a SD of 1. Similar to previous work [19,[23][24][25], the re-standardized scores were used in the regression analysis to allow comparison of associations across cognitive domains.…”

“…Although those taking an ARB had lower baseline volume of white matter hyperintensities, and lower prevalence of brain infarct or microbleeds, these differences were not statistically significant (all p>0. 19). The baseline association of ACEi and ARB use with total brain volume was similar in both groups (p for difference=0.99).…”